Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Philadelphia Chromosome Negative”

1,122 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,122 results

Early research (Phase 1)Looking for participantsNCT05866627
What this trial is testing

Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants

Who this might be right for
Healthy Volunteers
Bristol-Myers Squibb 76
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07394153
What this trial is testing

Pacritinib For Bone Marrow Fibrosis In Patients With Myelofibrosis Who Have Thrombocytopenia

Who this might be right for
Myelofibrosis，MF
Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas 30
Early research (Phase 1)Study completedNCT04199624
What this trial is testing

Assessment of Gastric pH Changes Induced by Ascorbic Acid Tablets

Who this might be right for
Hypochlorhydria
Indiana University 11
Not applicableStudy completedNCT02603094
What this trial is testing

Gastric pH in Intubated Children - Part Two

Who this might be right for
Preoperative Fasting
University Children's Hospital, Zurich 180
Testing effectiveness (Phase 2)Looking for participantsNCT06059690
What this trial is testing

Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells

Who this might be right for
Glioblastoma MultiformeGlycolytic IndexEpidermal Growth Factor Receptor
Jonsson Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT03624010
What this trial is testing

Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients

Who this might be right for
Hypertension Pulmonary Secondary Heart FailureRight Sided Heart Failure With Normal Ejection FractionHeart Failure With Normal Ejection Fraction
Tenax Therapeutics, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT01856283
What this trial is testing

Nilotinib 300 mg BID in Newly Diagnosed CP-CML Patients to Verify Disappearance of CD34+/Lin-Ph+ Cells

Who this might be right for
Leukemia, Myeloid, Chronic-Phase
Niguarda Hospital 87
Testing effectiveness (Phase 2)Active Not RecruitingNCT04164979
What this trial is testing

Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroEsophageal Cancer
University of California, Irvine 34
Not applicableNot Yet RecruitingNCT07397871
What this trial is testing

Salivary Flow, pH, and Buffering Capacity in Fixed and Clear Aligner Orthodontic Treatment

Who this might be right for
Orthodontic TreatmentSaliva
Riyadh Elm University 40
Not applicableNot Yet RecruitingNCT06615414
What this trial is testing

Cardiovascular Manifestations in Ph-negative MPN

Who this might be right for
Philadelphia Negative Myeloproliferative Neoplasms
Assiut University 80
Testing effectiveness (Phase 2)Study completedNCT05594784
What this trial is testing

Olverembatinib Combined With Reduced-Intensity Chemotherapy and Venetoclax for de Novo Ph+ ALL

Who this might be right for
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 79
Testing effectiveness (Phase 2)Ended earlyNCT04952753
What this trial is testing

Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC

Who this might be right for
Metastatic Colorectal Cancer
Novartis Pharmaceuticals 204
Early research (Phase 1)Ended earlyNCT02651727
What this trial is testing

Ph 1 Study of VS-4718, a FAK Inhibitor, in Combination With Nab-paclitaxel and Gemcitabine in Advanced Cancer Subjects

Who this might be right for
Pancreatic Cancer
Verastem, Inc. 13
Not applicableStudy completedNCT03629405
What this trial is testing

Assessment of the Efficacy and Barrier Protection of Two Cosmetic Products

Who this might be right for
Aged Skin
Dr. August Wolff GmbH & Co. KG Arzneimittel 20
Early research (Phase 1)Study completedNCT00588991
What this trial is testing

Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders

Who this might be right for
Adult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic LeukemiaAdult Acute Monocytic Leukemia+20 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT00006110
What this trial is testing

Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 82
Not applicableStudy completedNCT05452603
What this trial is testing

Usefulness of Wireless pH Monitoring in GERD Diagnosis

Who this might be right for
Gastroesophageal Reflux
Hospital de Clinicas José de San Martín 30
Post-approval studies (Phase 4)Ended earlyNCT02228382
What this trial is testing

Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors

Who this might be right for
Previously Treated PH + CML
Pfizer 163
Testing effectiveness (Phase 2)Active Not RecruitingNCT04081220
What this trial is testing

Hematology, IMG-7289, LSD1 (Lysine-Specific Demethylase 1) Inhibitor, Essential Thrombocythemia (ET), Ph 2

Who this might be right for
Thrombocythemia, Essential
The University of Texas Health Science Center at San Antonio 9
Early research (Phase 1)Study completedNCT01948843
What this trial is testing

Ph 1 ADI-PEG 20 Plus Doxorubicin; Patients With HER2 Negative Metastatic Breast Cancer

Who this might be right for
HER2 Negative Metastatic Breast Cancer
Polaris Group 15
Load More Results